DAY II / May 8 2021(SAT) 
한국시간, 
EDT (미국동부서머타임), 
CEST (중앙유럽서머타임)
| Time | Speaker |
|---|---|
| Session 1 | |
| 07:00 - 07:20 18:00 - 18:20
00:00 - 00:20 |
Anthony Rosenzweig Harvard Medical School New Targets in Heart Failure |
| 07:20 - 07:40 18:20 - 18:40
00:20 - 00:40 |
Pradeep Natarajan Massachusetts General Hospital Cardiovascular disease and clonal hematopoiesis of indeterminate potential |
| 07:40 - 08:00 18:40 - 19:00
00:40 - 01:00 |
Jennifer E Ho Harvard Medical School Unraveling HFpEF: a Systemic Disease |
| 08:00 - 08:20 |
Discussion |
| 08:20 - 08:30 |
Break Time |
| Session 2 | |
| 08:30 - 08:50 19:30 - 19:50
01:30 - 01:50 |
Siyeon Rhee Stanford University Single cell analysis reveals angiocrine factors that influence cardiomyocyte proliferation and maturation |
| 08:50 - 09:10 19:50 - 20:10
01:50 - 02:10 |
James Won Suk Jahng Kyungpook National University Modeling Diabetic cardiomyopathy in a dish: challenges and direction |
| 09:10-09:30 20:10 - 20:30
02:10 - 02:30 |
David T Paik Stanford University Organotypic specificity of endothelial cells |
| 09:30 - 09:50 |
Discussion |
| 09:50 - 10:00 |
Break Time |
| Session 3 | |
| 10:00 - 10:20 21:00 - 21:20
03:00 - 03:20 |
Joy Y Wu Stanford University The Role of Wnt Signaling in Health and Disease |
| 10:20 - 10:40 21:20 - 21:40
03:20 - 03:40 |
Chulan Kwon Johns Hopkins University Regulation of Cardiac Progenitor Cell Fate |
| 10:40 - 11:00 21:40 - 22:00
03:40 - 04:00 |
Stacey L Rentschler Washington University in St. Louis Wnt regulation of heart development and functio |
| 11:00 - 11:20 |
Discussion |
| 11:20 - 11:30 |
Break Time |
| Session 4 | |
| 11:30 - 11:50 22:30 - 22:50
04:30 - 04:50 |
Yoo-Wook Kwon Seoul National University KAI1 (CD82) is a key molecule to control angiogensis switch angiogenic milieu to quiescent state |
| 11:50 - 12:10 22:50 - 23:10
04:50 - 05:10 |
Hee Young Seok Seoul National University MiRNA oxidation and cardiac hypertrophy |
| 12:10 - 12:30 23:10 - 23:30
05:10 - 05:30 |
Injune Kim KAIST Sox17 deficiency promotes pulmonary arterial hypertension via HGF/c-Met signaling |
| 12:30 - 12:45 |
Discussion |
| 12:45 |
Closing |